RT Journal Article
SR Electronic
A1 Hoyle, Brian
T1 Tolvaptan Did Not Reduce Hospital Stay for Hyponatremia
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 20
SP 8
OP 9
DO 10.1177/155989771420003
UL http://mdc.sagepub.com/content/14/20/8.abstract
AB Hyponatremia is the most common clinically encountered serum electrolyte abnormality, occurring in 7% to 8% of elderly, ambulatory patients and 15% to 20% of hospitalized patients [Huda MS et al. Postgrad Med J 2006]. This article reports on a prospective clinical trial that evaluated the effect of the selective, competitive vasopressin 2 antagonist tolvaptan in the treatment of hyponatremia [Koren MJ et al. ICE ENDO 2014 (poster LBSA-0737)].